Using stem cells from umbilical cord to treat brain injuries

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of intravascular administration of mesenchymal stromal cells derived from Wharton's jelly of the umbilical cord on systemic immunomodulation and neuroinflammation in patients with traumatic brain injury (TBI). The study aims to explore the potential of these cells to improve neurological outcomes by modulating neuroinflammation and promoting recovery. Participants will receive either the stem cell treatment or a placebo, and their responses will be monitored through various assessments. The trial is designed to provide insights into the safety and efficacy of this innovative therapy for TBI.

Why it matters

Who can join: the full rules

20 healthy volunteers will be included for MRI normalization Volunteer eligibility criteria

Inclusion criteria :

* Age 18-50 years
* ASA 1 classification (healthy patient)

Exclusion criteria :

* Lack of written consent
* Neurological history likely to alter the image (epilepsy, transient ischaemic attack, meningitis, head trauma)
* Vulnerable person according to article L1121-6 of the CSP
* Protected adult person
* No affiliation to a social security regime
* Pregnancy
* Contraindication for MRI and PET-MRI

  * patients with Pacemaker and defibrillator
  * MR-incompatible prosthetic heart valve
  * Metallic intraocular, intra cerebral or intra medullary foreign bodies
  * Implantable neurostimulation systems
  * Cochlear implants/ear implant
  * Metallic fragments such as bullets, shotgun pellets, and metal shrapnel
  * Cerebral artery aneurysm clips
  * Ventriculo peritoneal shunt with metallic component generating significant artefacts on the MR sequence
  * Catheters with metallic components (Swan-Ganz catheter)
  * Patient unable to remain supine and motionless during the duration of the examination

    68 severe TBI patients with the following inclusion and exclusion criteria will be included"

Patient Inclusion criteria

* Age 18-50 years
* Severe TBI defined by:

  * Glasgow score \<12 within the 48 first hours,
  * Brain traumatic lesion on CT scan,
  * Need for intracranial pressure monitoring
* No other significant organ trauma (AIS \<2)
* Unresponsive to verbal commands 5 days after sedation discontinuation, for whom, after usual clinical and paraclinical evaluation there has been no decision to interrupt active therapies within 10 days after sedation discontinuation
* Written consent signed by the close relative

Patient Exclusion criteria

* History of disease or treatment impairing current or previous year immunity function ( hematologic disease (leukemia, myeloma), viral disease affecting immunity (like HIV), immunological treatment (corticoid, anti rejection medication, anti TNFα, chemotherapy)
* History of severe neurological or psychiatric disease likely to alter neurological assessment
* HTAP \> grade III OMS/WHO
* Ongoing uncontrolled infection with organ failure (septic shock, ARDS) including those due to severe COVID-19
* Platelets \<100 G/L or \<100000/μL, Hb \<8 g/dL, lymphocytes count \<1.5 G/L or 1500 μL , neutrophils count \< 2.5G/L or \<2500/μL, , creatinin \> 100 μmol/L
* Liver function abnormalities (bilirubin\> 2.5mg / dL or transaminases\> 5x the ULN). Patients with Gilbert's disease are eligible if liver tests are normal excluding bilirubinemia
* Known HIV seropositivity
* Neoplasia ongoing or treated in the 3 years before screening
* Bone marrow transplant recipient
* History of transfusion reaction or hypersensitivity
* Pregnancy
* Contraindication for MRI and PET-MRI:

  * Patient with Pacemaker and defibrillator
  * MR-incompatible prosthetic heart valve o Metallic intraocular, intra cerebral or intra medullary foreign bodies
  * Implantable neurostimulation systems o Cochlear implants/ ear implant
  * Metallic fragments such as bullets, shotgun pellets, and metal shrapnel
  * Cerebral artery aneurysm clips
  * Ventriculo peritoneal shunt with metallic component generating significant artefacts on the MR sequence
  * Catheters with metallic components (Swan-Ganz catheter)
  * Patient unable to remain supine and motionless during the duration of the examination
* Participation in another interventional clinical trial of an investigational therapy within 30 days of consent
* No affiliation to a social security regime
* Vulnerable person according to article L1121-6 of the CSP
* Protected adult person

Where it's running

• Hôpital National d'Instruction des Armées Percy
  Clamart, France Recruiting
• Beaujon Hospital
  Clichy, France Recruiting
• Hôpital de la Pitié Salpêtrière - AP-HP
  Paris, France Recruiting

Study contacts

• Principal investigator: Vincent DEGOS — Aphp
• Study coordinator: Vincent Degos
• Email: vincent.degos@aphp.fr
• Phone: 142163761

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• PIONEER-Prognosis: Using biomarkers and wearables to forecast recovery after mild traumatic brain injury

  This study tests whether blood biomarkers, health data from records, and wearables can help predict how people recover after a mild traumatic brain injury treated in the emergency department.

  Recruiting at 3 sites University of Michigan · Torrance, California and 4 other locations · NCT07858266

• HBOT to see if it helps cognition and well‑being in first responders with prior brain injury

  This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.

  Recruiting Phase 2 Summit Hyperbarics and Wellness · Boise, Idaho · NCT07852728

• Depth Electrode Monitoring after Traumatic Brain Injury

  This study tests adding a depth electrode with continuous brain monitoring during external ventricular drain placement in adults with traumatic brain injury to see if cortical reverberation signals can be tracked safely.

  Recruiting Hennepin Healthcare Research Institute · Minneapolis, Minnesota · NCT07842458

• Understanding growth hormone deficiency after a brain injury in adults

  This observational study tests whether growth hormone deficiency affects quality of life and symptoms in adults with traumatic brain injury and whether GH replacement helps after 12 weeks.

  Recruiting University of Calgary · Calgary, Alberta and 1 other locations · NCT07795736

• Electrical stimulation-assisted exercise for people with lower limb paralysis

  This study tests whether adding electrical stimulation during exercise can improve leg muscle strength and endurance for people with paralysis.

  Recruiting Louis Stokes VA Medical Center · Cleveland, Ohio · NCT07768761

• ZEPU-2000 robotic rehab for arm and leg weakness

  This trial tests whether adding ZEPU-2000A, ZEPU-2000D, and ZEPU-2000E robotic rehabilitation to usual therapy helps adults with arm/leg movement problems from stroke, incomplete SCI, TBI, or related conditions.

  Recruiting Bangladesh Medical University · Dhaka · NCT07749612

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.